Trial Profile
Drug Use Investigation Of Selara(Registered). Tablets(an Investigation For Chronic Heart Failure)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jul 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Chronic heart failure
- Focus Adverse reactions
- Sponsors Pfizer
- 28 Jul 2020 Status changed from recruiting to completed.
- 23 Mar 2020 Planned End Date changed from 28 Feb 2020 to 18 Jun 2020.
- 23 Mar 2020 Planned primary completion date changed from 28 Feb 2020 to 18 Jun 2020.